SAN FRANCISCO, March 16, 2017 /PRNewswire/ -- Kindred
Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company
focused on saving and improving the lives of pets, today announced
that Dr. Richard Chin, Chief
Executive Officer, will be presenting at the 2017 Jefferies Animal
Health Summit in New York, NY on
Thursday, March 30, 2017 at
10:45 AM EDT.
This conference will not be webcast. Investors and other
interested parties may access the corporate presentation following
this meeting at http://kindredbio.com/jefferies2017.
About Kindred Biosciences
Kindred Biosciences is a development-stage biopharmaceutical
company focused on saving and improving the lives of pets. Its
mission is to bring to pets the same kinds of safe and effective
medicines that human family members enjoy. The Company's strategy
is to identify compounds and targets that have already demonstrated
safety and efficacy in humans and to develop therapeutics based on
these validated compounds and targets for dogs, cats and
horses. The Company has a deep pipeline of novel drugs and
biologics in development across many therapeutic classes.
For more information or to download the corporate presentation,
visit www.KindredBio.com/LearnMore. Stay connected with KindredBio
on Facebook at www.Facebook.com/KindredBio.
Contact
Russell Radefeld
KindredBio
russell.radefeld@kindredbio.com
(650) 701-7904
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-2017-jefferies-animal-health-summit-300424922.html
SOURCE Kindred Biosciences, Inc.